Laboratorios Farmaceuticos (Spain) Price Prediction
| ROVI Stock | EUR 63.05 0.05 0.08% |
Oversold Vs Overbought
31
Oversold | Overbought |
Using Laboratorios Farmaceuticos hype-based prediction, you can estimate the value of Laboratorios Farmaceuticos ROVI from the perspective of Laboratorios Farmaceuticos response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Laboratorios Farmaceuticos to buy its stock at a price that has no basis in reality. In that case, they are not buying Laboratorios because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Laboratorios Farmaceuticos after-hype prediction price | EUR 63.05 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Laboratorios |
Laboratorios Farmaceuticos After-Hype Price Prediction Density Analysis
As far as predicting the price of Laboratorios Farmaceuticos at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Laboratorios Farmaceuticos or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Laboratorios Farmaceuticos, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Laboratorios Farmaceuticos Estimiated After-Hype Price Volatility
In the context of predicting Laboratorios Farmaceuticos' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Laboratorios Farmaceuticos' historical news coverage. Laboratorios Farmaceuticos' after-hype downside and upside margins for the prediction period are 60.68 and 65.42, respectively. We have considered Laboratorios Farmaceuticos' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Laboratorios Farmaceuticos is very steady at this time. Analysis and calculation of next after-hype price of Laboratorios Farmaceuticos is based on 3 months time horizon.
Laboratorios Farmaceuticos Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Laboratorios Farmaceuticos is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Laboratorios Farmaceuticos backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Laboratorios Farmaceuticos, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.29 | 2.37 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
63.05 | 63.05 | 0.00 |
|
Laboratorios Farmaceuticos Hype Timeline
Laboratorios Farmaceuticos is at this time traded for 63.05on Madrid Exchange of Spain. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Laboratorios is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.29%. %. The volatility of related hype on Laboratorios Farmaceuticos is about 0.0%, with the expected price after the next announcement by competition of 63.05. About 60.0% of the company outstanding shares are owned by corporate insiders. The book value of Laboratorios Farmaceuticos was at this time reported as 8.28. The company last dividend was issued on the 5th of July 2022. Assuming the 90 days trading horizon the next forecasted press release will be within a week. Check out Laboratorios Farmaceuticos Basic Forecasting Models to cross-verify your projections.Laboratorios Farmaceuticos Related Hype Analysis
Having access to credible news sources related to Laboratorios Farmaceuticos' direct competition is more important than ever and may enhance your ability to predict Laboratorios Farmaceuticos' future price movements. Getting to know how Laboratorios Farmaceuticos' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Laboratorios Farmaceuticos may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ENC | ENCE Energa y | 0.00 | 0 per month | 0.00 | (0.16) | 2.19 | (2.14) | 7.45 | |
| VIS | Viscofan | 0.00 | 0 per month | 0.95 | (0.07) | 1.60 | (1.76) | 5.82 | |
| VID | Vidrala SA | 0.00 | 0 per month | 1.23 | (0.05) | 3.20 | (1.97) | 10.09 | |
| EBRO | Ebro Foods | 0.00 | 0 per month | 0.69 | (0.15) | 1.02 | (1.23) | 3.29 |
Laboratorios Farmaceuticos Additional Predictive Modules
Most predictive techniques to examine Laboratorios price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Laboratorios using various technical indicators. When you analyze Laboratorios charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Laboratorios Farmaceuticos Predictive Indicators
The successful prediction of Laboratorios Farmaceuticos stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Laboratorios Farmaceuticos ROVI, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Laboratorios Farmaceuticos based on analysis of Laboratorios Farmaceuticos hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Laboratorios Farmaceuticos's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Laboratorios Farmaceuticos's related companies.
Story Coverage note for Laboratorios Farmaceuticos
The number of cover stories for Laboratorios Farmaceuticos depends on current market conditions and Laboratorios Farmaceuticos' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Laboratorios Farmaceuticos is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Laboratorios Farmaceuticos' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Laboratorios Farmaceuticos Short Properties
Laboratorios Farmaceuticos' future price predictability will typically decrease when Laboratorios Farmaceuticos' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Laboratorios Farmaceuticos ROVI often depends not only on the future outlook of the potential Laboratorios Farmaceuticos' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Laboratorios Farmaceuticos' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 55.4 M | |
| Cash And Short Term Investments | 99 M |
Complementary Tools for Laboratorios Stock analysis
When running Laboratorios Farmaceuticos' price analysis, check to measure Laboratorios Farmaceuticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorios Farmaceuticos is operating at the current time. Most of Laboratorios Farmaceuticos' value examination focuses on studying past and present price action to predict the probability of Laboratorios Farmaceuticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorios Farmaceuticos' price. Additionally, you may evaluate how the addition of Laboratorios Farmaceuticos to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stocks Directory Find actively traded stocks across global markets |